AIM
IDXX icon

Aster Investment Management’s Idexx Laboratories IDXX Stock Holding History

Aster Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$32.3M Buy
+720,000
New +$31.5M 1.2% 35

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Aster Investment Management's IDXX Position: Q2 2013 in Review

Aster Investment Management opened a new position in Idexx Laboratories (IDXX) in Q2 2013: 720,000 shares worth $32.3M. The stake represents 1.2% of the portfolio and ranks #35 among its holdings.

272 funds tracked by Wall St. Rank hold IDXX as of Q2 2013.

  • Aster Investment Management held 720,000 shares of Idexx Laboratories worth $32.3M as of Q2 2013.
  • Idexx Laboratories was a new Aster Investment Management position in Q2 2013.
  • Idexx Laboratories made up 1.2% of Aster Investment Management's portfolio in Q2 2013, its #35 holding.
  • 272 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2013.

Based on Aster Investment Management's 13F filing for Q2 2013, filed 29 Jul 2013.